TGR5, Not Only a Metabolic Regulator

被引:188
作者
Guo, Cong [1 ]
Chen, Wei-Dong [2 ,3 ]
Wang, Yan-Dong [1 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Chem Resource Engn, Beijing, Peoples R China
[2] Henan Univ, Key Lab Receptors Mediated Gene Regulat & Drua Di, Sch Med, Kaifeng, Peoples R China
[3] Inner Mongolia Med Univ, Sch Basic Med Sci, Key Lab Mol Pathol, Hohhot, Peoples R China
基金
中国国家自然科学基金;
关键词
TGR5; Gpbar1; GPCR; bile acids; receptor; BILE-ACID RECEPTOR; NF-KAPPA-B; GPBAR1; TGR5; ACTIVATION; LIVER; INFLAMMATION; CANCER; CELLS; STAT3; DIFFERENTIATION;
D O I
10.3389/fphys.2016.00646
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
G-protein-coupled bile acid receptor, Gpbar1 (TGR5), is a member of G-protein-coupled receptor (GPCR) superfamily. High levels of TGR5 mRNA were detected in several tissues such as small intestine, stomach, liver, lung, especially in placenta and spleen. TGR5 is not only the receptor for bile acids, but also the receptor for multiple selective synthetic agonists such as 6 alpha-ethyl-23(3)-methyl-cholic acid (6-EMCA, INT-777) and a series of 4-benzofuranyloxynicotinamde derivatives to regulate different signaling pathways such as nuclear factor kappa B (NF-kappa B), AKT, and extracellular signal-regulated kinases (ERK). TGR5, as a metabolic regulator, is involved in energy homeostasis, bile acid homeostasis, as well as glucose metabolism. More recently, our group and others have extended the functions of TGR5 to more than metabolic regulation, which include inflammatory response, cancer and liver regeneration. These findings highlight TGR5 as a potential drug target for different diseases. This review summarizes the basic information of TGR5 and its new functions.
引用
收藏
页数:9
相关论文
共 88 条
[61]   Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex [J].
Sarbassov, DD ;
Guertin, DA ;
Ali, SM ;
Sabatini, DM .
SCIENCE, 2005, 307 (5712) :1098-1101
[62]  
Sarode Gargi S, 2015, J Contemp Dent Pract, V16, P595
[63]   Significance of AKT in gastric cancer (Review) [J].
Sasaki, Takamitsu ;
Kuniyasu, Hiroki .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (06) :2187-2192
[64]   Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea [J].
Sato, Hiroyuki ;
Genet, Cedric ;
Strehle, Axelle ;
Thomas, Charles ;
Lobstein, Annelise ;
Wagner, Alain ;
Mioskowski, Charles ;
Auwerx, Johan ;
Saladin, Regis .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (04) :793-798
[65]  
Shacter E, 2002, ONCOLOGY-NY, V16, P217
[66]   MECHANISMS IN ENDOCRINOLOGY Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion [J].
Sonne, David P. ;
Hansen, Morten ;
Knop, Filip K. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (02) :R47-R65
[67]   Regulation of nuclear factor-κB in autoimmunity [J].
Sun, Shao-Cong ;
Chang, Jae-Hoon ;
Jin, Jin .
TRENDS IN IMMUNOLOGY, 2013, 34 (06) :282-289
[68]  
Teng Yong, 2014, JAKSTAT, V3, pe28086, DOI 10.4161/jkst.28086
[69]   TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders [J].
Tiwari, Atul ;
Maiti, Pranab .
DRUG DISCOVERY TODAY, 2009, 14 (9-10) :523-530
[70]   Receptor proximal kinases in NF-κB signaling as potential therapeutic targets in cancer and inflammation [J].
Verstrepen, Lynn ;
Beyaert, Rudi .
BIOCHEMICAL PHARMACOLOGY, 2014, 92 (04) :519-529